KYLE FEHLIS: Open Payments
NPI 1215167119 · NEW BRAUNFELS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,150 in 34 payments from 21 companies in 2025. Trend: 2023 $469 · 2024 $568 · 2025 $1,150
Food & beverage: $1,150
| Company | Payments | Amount |
|---|---|---|
| Caldera Medical, Inc | 2 | $252 |
| AERIN MEDICAL INC. | 1 | $135 |
| Phathom Pharmaceuticals, Inc. | 2 | $105 |
| Lilly USA, LLC | 4 | $78 |
| Radius Health, Inc. | 2 | $66 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Corcept Therapeutics | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $37 |
| ABBVIE INC. | 2 | $36 |
Products named: VIVAER STYLUS, VOQUEZNA, REXULTI, MOUNJARO, Korlym, JARDIANCE, FARXIGA, Quviviq.
Industry payments across TX — which companies pay providers there.
